Fig. 2.
![Fig. 2. Comparison of SUV[max] (⧫) and the metabolic rate of FDG (MRFDG) (▪) at (A) day 7 and (B) day 42 in patients with relapse (n = 5) and complete response (CR; n = 6).](https://ash.silverchair-cdn.com/ash/content_public/journal/blood/91/12/10.1182_blood.v91.12.4464/4/blod41208002ax.jpeg?Expires=1735834407&Signature=bLiEXTLmZ8G66ak~4Rziwkhdg5naVqBlkRykQ1iqzYY1Lc1MtyMDZvTAqKiS7TCqeDd2hY0KLOq-WYJ-1UBxePzFqjgWO3jQAypCSb3Zb5D7aolKJeGXFnsfDlO~axwSKkBGlELaGP9-1plRDbr4DIlfZs7De39dEg56SmBHOL6iwiEx6M3o9hfOkYujEt3QCVeTOPX8uC8uoEbIAIDlkXWDg94OCT4wMfaA~hd8dszCWI9jqpL7AkALw2HlTrZXAYMN8BRcTjKpjPQb-iSVrlEVHOBM93367rgt1D-sYph~oU9WvmNEgCjhzPODcmA~clTKoldgCje0TbAJf7tAzw__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Comparison of SUV[max] (⧫) and the metabolic rate of FDG (MRFDG) (▪) at (A) day 7 and (B) day 42 in patients with relapse (n = 5) and complete response (CR; n = 6).
Comparison of SUV[max] (⧫) and the metabolic rate of FDG (MRFDG) (▪) at (A) day 7 and (B) day 42 in patients with relapse (n = 5) and complete response (CR; n = 6).
